Recent Investment Analysts’ Ratings Changes for IMAX (IMAX)

Several brokerages have updated their recommendations and price targets on shares of IMAX (NYSE: IMAX) in the last few weeks:

• 10/23/2026 – IMAX had its “buy” rating reaffirmed by Roth Capital. They now have a $62.00 price target on the stock.
• 10/23/2026 – IMAX had its price target raised by JPMorgan Chase & Co. from $50.00 to $58.00. They now have an “overweight” rating on the stock.
• 10/15/2026 – IMAX had its price target raised by Wells Fargo & Company from $45.00 to $55.00. They now have an “equal weight” rating on the stock.
• 10/14/2026 – IMAX had its price target raised by Wedbush from $54.00 to $60.00. They now have an “outperform” rating on the stock.
• 10/14/2026 – IMAX had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $65.00 price target on the stock.
• 10/10/2026 – IMAX was upgraded by Wall Street Zen from “hold” to “buy”.
• 10/9/2026 – IMAX was upgraded by Zacks Research from “hold” to “strong-buy”.
• 10/8/2026 – IMAX was upgraded by Weiss Ratings from “buy (b-)” to “buy (b)”.
• 10/8/2026 – IMAX had its price target raised by B. Riley Financial from $61.00 to $64.00. They now have a “buy” rating on the stock.
• 10/7/2026 – IMAX was given a new $65.00 price target by UBS Group.
• 9/26/2026 – IMAX was downgraded by Wall Street Zen from “buy” to “hold”.
• 9/24/2026 – IMAX is now covered by Morgan Stanley. They set an “overweight” rating and a $63.00 price target on the stock.
• 9/9/2026 – IMAX had its price target raised by Rosenblatt Securities from $60.00 to $65.00. They now have a “buy” rating on the stock.
• 9/5/2026 – IMAX was upgraded by Wall Street Zen from “hold” to “buy”.
• 9/4/2026 – IMAX had its price target raised by The Goldman Sachs Group from $42.00 to $50.00. They now have a “neutral” rating on the stock.
• 9/3/2026 – IMAX had its price target raised by Roth Capital from $50.00 to $60.00. They now have a “buy” rating on the stock.

Insider Buying and Selling at IMAX

In other IMAX news, CFO Natasha Fernandes sold 20,000 shares of the firm’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $54.63, for a total transaction of $1,092,600.00. Following the completion of the transaction, the chief financial officer owned 35,596 shares in the company, valued at $1,944,609.48. This trade represents a 35.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Kenneth Weissman sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $54.54, for a total transaction of $436,320.00. Following the transaction, the insider owned 28,205 shares of the company’s stock, valued at approximately $1,538,300.70. This represents a 22.10% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 507,257 shares of company stock valued at $26,673,571 in the last 90 days. Insiders own 20.55% of the company’s stock.

IMAX Corporation (NYSE: IMAX) is a global entertainment technology company that specializes in premium large-format cinema experiences. The company designs and supplies specialized theater systems that combine large screens, high-resolution projection, advanced sound, and immersive theater design to present feature films, documentaries, live events, and other content.

IMAX supports its theater partners with projection and sound equipment, theater design and installation services, and technology and maintenance support.